Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Explore various investment strategies in the energy sector to boost your financial portfolio. Stay informed about trends and opportunities in this dynamic industry.
23,467 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
On March 25, 2026, ramsey calls $800k worth behavior sparked a debate about wealth, budgeting, and how much spending ...
Bitcoin hovers around 82,000 as traders assess whether the bear market bottom when will be confirmed. A sustained ETF...
A federal court unsealed a document described as an alleged Epstein suicide note after a request by The New York Time...
In today’s stock market today, Nokia priced lower by about 6% as traders weigh AI hype against fundamentals. This pie...
Granite Ridge delivered a solid start to 2026 with steady revenue growth and improving margins. This article breaks d...
Is it a good time amazon stock? depends on your goals and horizon. This guide breaks down the key signals, risks, and...
In a choppy market, Comcast trades as a value play with a solid dividend, while Netflix offers growth upside but high...
As markets wobble in 2026, suze orman’s sober advice guides grieving spouses to pause large financial actions for six...
Solesence kicked off 2026 with a solid Q1 showing across core segments. This deep dive breaks down the numbers, what ...
Apple reveals a staggering pay gap in its 2025 proxy, with CEO compensation at roughly $74 million vs. a median emplo...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...